Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
Effectiveness of psychologically focused group interventions for Multiple Sclerosis: A review of the experimental literature.
Temporally Consistent Probabilistic Detection of New Multiple Sclerosis Lesions in Brain MRI.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Commentary.
FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test.
Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
Environmental enrichment and brain repair: Harnessing the therapeutic effects of cognitive stimulation and physical activity to enhance experience-dependent plasticity.
Comparison of 3D Cube FLAIR with 2D FLAIR for Multiple Sclerosis Imaging at 3 Tesla.
Hormonal and gender-related immune changes in multiple sclerosis.
Demyelinating CNS Lesions in a Teenager.
No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis.
[STUDY ON RELATIONSHIP BETWEEN DIFFUSION TENSOR IMAGING AND VISUAL EVOKED POTENTIAL IN VISUAL PATHWAY OF NEUROMYELITIS OPTICA].
A web-based decision support tool for prognosis simulation in multiple sclerosis.
Multiple sclerosis in malaysia: demographics, clinical features, and neuroimaging characteristics.
Stop the silent misdiagnosis: patients' preferences matter.
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
Docosahexaenoic Acid and Cognition throughout the Lifespan.
Oligodendrogenesis in the normal and pathological central nervous system.
From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
514
515
516
517
518
519
520
521
522
…
next ›
last »